Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.69 USD | +0.23% | -0.39% | +7.17% |
Apr. 04 | Boston Scientific, Axonics Receive FTC Second Request on Merger Deal | MT |
Apr. 04 | Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information | DJ |
Evolution of the average Target Price on Axonics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Axonics, Inc.
Needham & Co. | |
Truist Securities | |
Leerink Partners | |
CL King | |
Piper Sandler | |
Wells Fargo Securities | |
Nephron Research | |
Wolfe Research | |
RBC Capital Markets | |
Morgan Stanley | |
Baird | |
KeyBanc Capital Markets | |
Mizuho Securities | |
Jefferies & Co. | |
BofA Securities | |
SVB Leerink | |
Barclays |
EPS Revisions
- Stock Market
- Equities
- AXNX Stock
- Consensus Axonics, Inc.